Search

Humana Inc

Slēgts

SektorsVeselības aprūpe

401.36 -1.14

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

397.33

Max

406.51

Galvenie mērījumi

By Trading Economics

Ienākumi

-491M

693M

Pārdošana

1.2B

41B

P/E

Sektora vidējais

36.498

56.659

EPS

7.61

Dividenžu ienesīgums

0.92

Peļņas marža

1.696

Darbinieki

67,060

EBITDA

-658M

1.3B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+7.05% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

0.92%

2.18%

Nākamie ieņēmumi

2026. g. 4. nov.

Nākamais dividenžu datums

2026. g. 27. nov.

Nākamais Ex dividenžu datums

2026. g. 30. sept.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-724M

46B

Iepriekšējā atvēršanas cena

402.5

Iepriekšējā slēgšanas cena

401.36

Ziņu noskaņojums

By Acuity

26%

74%

58 / 339 Rangs Healthcare

Humana Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 3. sept. 20:07 UTC

News

Humana Inc has earned the 2026 Great Place To Work Certification, contributing to positive investor sentiment as shares advance during Thursday's session.

2026. g. 2. sept. 20:08 UTC

News

Humana Inc. shares are advancing as the company declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026.

2026. g. 1. sept. 20:01 UTC

News
Event

Humana Inc. reaffirmed its fiscal year 2026 guidance, projecting at least $9 adjusted EPS, contributing to a positive market reaction and higher shares.

2026. g. 27. aug. 19:46 UTC

News

Humana has partnered with DaVita to enhance care for Medicare Advantage members with chronic kidney disease. Shares are advancing amid positive market sentiment.

2026. g. 26. aug. 20:08 UTC

Humana Inc shares are higher today amid mixed market performance and inflation data showing a slight consumer price increase in July.

2026. g. 25. aug. 22:02 UTC

Humana Inc shares are higher in after-market hours, rebounding from session lows despite a broader market pullback and declining consumer confidence.

2026. g. 24. aug. 20:06 UTC

News

Wolfe Research raised Humana's price target to $450, maintaining an Outperform rating. Shares are higher today, reflecting positive sentiment from the upgrade.

2026. g. 21. aug. 19:31 UTC

Humana Inc. shares are advancing, reflecting a broader rebound in U.S. stocks amid ongoing economic uncertainties. They pulled back earlier but regained momentum.

2026. g. 20. aug. 19:36 UTC

News

Humana Inc. appointed Dr. Shantanu Nundy as Chief Medical Officer, effective August 31. Shares are higher since Wednesday's close amid this leadership change.

2026. g. 19. aug. 19:51 UTC

News

Humana Inc. shares are lower, impacted by a significant decline in the Managed Health Care sub-sector. The company continues expanding its home-based care initiative.

2026. g. 18. aug. 19:16 UTC

Humana Inc shares are lower amid broader market weakness and rising U.S. Treasury yields, despite an earlier recovery during the session.

2026. g. 14. aug. 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

2026. g. 12. aug. 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

2026. g. 10. aug. 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

2026. g. 7. aug. 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

2026. g. 6. aug. 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

2026. g. 5. aug. 19:56 UTC

News
Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

2026. g. 4. aug. 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

2026. g. 3. aug. 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

2026. g. 31. jūl. 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

2026. g. 30. jūl. 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

2026. g. 29. jūl. 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

2026. g. 28. jūl. 23:16 UTC

News
Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

2026. g. 27. jūl. 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

2026. g. 24. jūl. 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

2026. g. 22. jūl. 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

2026. g. 20. jūl. 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Salīdzinājums

Cenas izmaiņa

Humana Inc Prognoze

Cenas mērķis

By TipRanks

7.05% augšup

Prognoze 12 mēnešiem

Vidējais 429.86 USD  7.05%

Augstākais 624 USD

Zemākais 280 USD

Pamatojoties uz 23 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Humana Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

23 ratings

11

Pirkt

11

Turēt

1

Pārdot

Noskaņojums

By Acuity

58 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
help-icon Live chat